Human Molecular Genetics Advance Access published online on January 26, 2006
Human Molecular Genetics, doi:10.1093/hmg/ddl001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Urology, Shiga University of Medical Science, Otsu, Shiga, 520-2192, Japan; Department of Clinical Laboratory Medicine, Shiga University of Medical Science, Shiga, Japan
* To whom correspondence should be addressed. A common deletion at chromosomal arm 14q32 in human renal cell carcinoma (RCC) prompted us to explore a tumor suppressor gene (TSG) in this region. We report that imprinted DLK1 at 14q32, a regulator of adipocyte differentiation, is a candidate TSG in RCCs. DLK1 expression was lost in 39 out of 50 (78%) primary RCC tissues while expression of DLK1 was maintained in every normal kidney tissue examined. DLK1 was expressed in only one of 15 (7%) RCC derived cell lines. In order to see the biological significance of DLK1 inactivation in RCCs, we tested the effect of restoration of DLK1 in RCC cell lines using a recombinant retrovirus containing the gene. Reintroduction of DLK1 into DLK1-null RCC cell lines markedly increased anchorage-independent cell death, anoikis, and suppressed tumor growth in nude mice. We then investigated the underlying mechanisms for DLK1 inactivation in RCCs. We found LOH at this region in 12 out of 50 RCC tissues (24%). To explore the role of epigenetic regulation of DLK1 inactivation in RCCs, we conducted methylation analysis of the upstream region and gene body of DLK1. We could not find a differentially methylated region (DMR) in either the upstream region or the gene body of DLK1. However, we found that gain of methylation upstream of GTL2, a reciprocal imprinted gene for DLK1, is a critical epigenetic alteration for the inactivation of DLK1 in RCCs. The present data have shown that gain of methylation upstream of the untranslated GTL2 leads to pathological down regulation of DLK1 in RCCs.
Received November 24, 2005
Revised January 21, 2006
Accepted January 21, 2006
Article
Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma
Takahiro Kawakami 1 *,
Tokuhiro Chano 2,
Kahori Minami 3,
Hidetoshi Okabe 3,
Yusaku Okada 4,
and
Keisei Okamoto 4
2 Department of Clinical Laboratory Medicine, Shiga University of Medical Science, Shiga, Japan; PRESTO, Japan Science and Technology Agency, Saitama, Japan.
3 Department of Clinical Laboratory Medicine, Shiga University of Medical Science, Shiga, Japan
4 Department of Urology, Shiga University of Medical Science, Shiga, Japan
Takahiro Kawakami, E-mail: tkawa{at}belle.shiga-med.ac.jp
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Kobayashi, A. Sato, E. Otsu, H. Hiura, C. Tomatsu, T. Utsunomiya, H. Sasaki, N. Yaegashi, and T. Arima Aberrant DNA methylation of imprinted loci in sperm from oligospermic patients Hum. Mol. Genet., November 1, 2007; 16(21): 2542 - 2551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Donsante, D. G. Miller, Y. Li, C. Vogler, E. M. Brunt, D. W. Russell, and M. S. Sands AAV Vector Integration Sites in Mouse Hepatocellular Carcinoma Science, July 27, 2007; 317(5837): 477 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Huang, X. Zhang, M. Zhang, J.-D. Zhu, Y.-L. Zhang, Y. Lin, K.-S. Wang, X.-F. Qi, Q. Zhang, G.-Z. Liu, et al. Up-regulation of DLK1 as an imprinted gene could contribute to human hepatocellular carcinoma Carcinogenesis, May 1, 2007; 28(5): 1094 - 1103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. M. Abdallah, P. Boissy, Q. Tan, J. Dahlgaard, G. A. Traustadottir, K. Kupisiewicz, J. Laborda, J.-M. Delaisse, and M. Kassem dlk1/FA1 Regulates the Function of Human Bone Marrow Mesenchymal Stem Cells by Modulating Gene Expression of Pro-inflammatory Cytokines and Immune Response-related Factors J. Biol. Chem., March 9, 2007; 282(10): 7339 - 7351. [Abstract] [Full Text] [PDF]
|
|